:

PARIS STARTUP SQUAREMIND RAISES $18M FOR AI SKIN IMAGING ROBOT

AI DESK1 MIN READ
TUE, APR 28, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

SquareMind, a Paris-based medtech company, has secured $18 million in funding for its Swan robot, which uses AI to perform full-body dermoscopic skin imaging. The round included a previously undisclosed pre-Series A investment.

The funding includes backing from Sonder Capital, the venture firm founded by Fred Moll, a notable figure in medical robotics. SquareMind's Swan platform combines robotics with artificial intelligence to automate dermoscopic skin imaging across the entire body. The technology addresses a key challenge in dermatology: standardizing and scaling skin cancer screening while reducing manual labor and human error. Dermoscopic imaging allows clinicians to examine skin lesions at magnified levels to identify potential melanomas and other skin conditions. Automating this process with robotics could streamline workflows in dermatology clinics and hospitals. The $18 million raise signals growing investor interest in AI-powered medical robotics, particularly in areas where automation can enhance diagnostic accuracy and clinical efficiency. The funding will likely support further product development and commercial expansion for SquareMind's platform.

■ SOURCES

Techmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

MAY 29AI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

MAY 29AI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

MAY 29AI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

MAY 29Industry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.